SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Clinical trials for SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with thickened hearts
Disease control Recruiting nowThis study is testing whether a drug called aficamten is safe and effective for children and teenagers with a genetic condition that causes the heart muscle to thicken, making it harder to pump blood. Participants will take the drug or a placebo for 12 weeks, followed by a longer…
Matched conditions: SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE2, PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New heart drug trial offers hope for indian patients with genetic heart condition
Disease control Recruiting nowThis study is testing an existing heart medication called mavacamten in Indian adults with a genetic heart condition that causes the heart muscle to thicken and obstruct blood flow. Researchers want to see how safe and effective the drug is specifically for this population over 3…
Matched conditions: SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC